{"database": "lobbying", "table": "lobbying_activities", "rows": [[1354260, "51e8068b-8d08-475e-8eb6-a51ed172a7ab", "Q4", "EMERGENT BIOSOLUTIONS INC.", 304931, "EMERGENT BIOSOLUTIONS INC", 2012, "fourth_quarter", "DIS", "HR 5855 and S 3216 - Department of Homeland Security Appropriations, 2013 - provisions relating to development, acquistion and stockpiling of biodefense vaccines;\nS. 3295 & House draft bill - Departments of Labor, Health & Human Services & Education Appropriations Act, 2013 - same as above; HR 2356 - WMD Prevention and Preparedness Act of 2012 - provisions relating to acquisition and stockpiling of biodefense vaccines;\nHR 2405 and S.1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including BioMedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs).", "HOUSE OF REPRESENTATIVES,SENATE", null, 630000, 0, 0, "2013-01-22T13:54:35.570000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1354260"], "units": {}, "query_ms": 0.2749949926510453, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}